POET TECHNOLOGIES INC (PTK.CA)

CA73044W3021 - Common Stock

6.59  -0.66 (-9.1%)

Fundamental Rating

3

Overall PTK gets a fundamental rating of 3 out of 10. We evaluated PTK against 3 industry peers in the Semiconductors & Semiconductor Equipment industry. While PTK seems to be doing ok healthwise, there are quite some concerns on its profitability. PTK is valued expensive and it does not seem to be growing.



2

1. Profitability

1.1 Basic Checks

In the past year PTK has reported negative net income.
In the past year PTK has reported a negative cash flow from operations.
In the past 5 years PTK always reported negative net income.
In the past 5 years PTK always reported negative operating cash flow.

1.2 Ratios

With an excellent Return On Assets value of -63.17%, PTK belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
PTK's Return On Equity of -104.21% is amongst the best of the industry. PTK outperforms 100.00% of its industry peers.
Industry RankSector Rank
ROA -63.17%
ROE -104.21%
ROIC N/A
ROA(3y)-141.78%
ROA(5y)-121.23%
ROE(3y)-219.16%
ROE(5y)-200.3%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for PTK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

4

2. Health

2.1 Basic Checks

PTK does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for PTK has been increased compared to 1 year ago.
PTK has more shares outstanding than it did 5 years ago.
PTK has a worse debt/assets ratio than last year.

2.2 Solvency

PTK has an Altman-Z score of 3.21. This indicates that PTK is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of PTK (3.21) is better than 66.67% of its industry peers.
A Debt/Equity ratio of 0.01 indicates that PTK is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.01, PTK is doing good in the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 3.21
ROIC/WACCN/A
WACC13.01%

2.3 Liquidity

A Current Ratio of 2.20 indicates that PTK has no problem at all paying its short term obligations.
PTK has a Current ratio of 2.20. This is in the lower half of the industry: PTK underperforms 66.67% of its industry peers.
A Quick Ratio of 2.20 indicates that PTK has no problem at all paying its short term obligations.
The Quick ratio of PTK (2.20) is worse than 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 2.2
Quick Ratio 2.2

3

3. Growth

3.1 Past

The earnings per share for PTK have decreased strongly by -13.46% in the last year.
PTK shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -78.58%.
EPS 1Y (TTM)-13.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-53.85%
Revenue 1Y (TTM)-78.58%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

PTK is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.09% yearly.
The Revenue is expected to grow by 290.49% on average over the next years. This is a very strong growth
EPS Next Y17%
EPS Next 2Y19.16%
EPS Next 3Y22.09%
EPS Next 5YN/A
Revenue Next Year-89.98%
Revenue Next 2Y214.13%
Revenue Next 3Y327.29%
Revenue Next 5Y290.49%

3.3 Evolution

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PTK. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PTK. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PTK's earnings are expected to grow with 22.09% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y19.16%
EPS Next 3Y22.09%

0

5. Dividend

5.1 Amount

PTK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

POET TECHNOLOGIES INC

TSX-V:PTK (1/13/2025, 7:00:00 PM)

6.59

-0.66 (-9.1%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)11-14 2024-11-14/amc
Earnings (Next)N/A N/A
Inst Owners5.24%
Inst Owner ChangeN/A
Ins Owners0.76%
Ins Owner ChangeN/A
Market Cap504.13M
Analysts82.5
Price Target8.73 (32.47%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-91.59%
Min EPS beat(2)-130.68%
Max EPS beat(2)-52.51%
EPS beat(4)0
Avg EPS beat(4)-52.91%
Min EPS beat(4)-130.68%
Max EPS beat(4)-10.83%
EPS beat(8)3
Avg EPS beat(8)-25.69%
EPS beat(12)5
Avg EPS beat(12)-17.32%
EPS beat(16)8
Avg EPS beat(16)-15.47%
Revenue beat(2)0
Avg Revenue beat(2)-96.73%
Min Revenue beat(2)-100%
Max Revenue beat(2)-93.46%
Revenue beat(4)1
Avg Revenue beat(4)-45.16%
Min Revenue beat(4)-100%
Max Revenue beat(4)111.77%
Revenue beat(8)1
Avg Revenue beat(8)-38.36%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.29%
PT rev (3m)13.86%
EPS NQ rev (1m)0%
EPS NQ rev (3m)30%
EPS NY rev (1m)0%
EPS NY rev (3m)-6.41%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-88.89%
Revenue NY rev (1m)-62.45%
Revenue NY rev (3m)-92.88%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2915.91
P/FCF N/A
P/OCF N/A
P/B 11.42
P/tB 11.64
EV/EBITDA N/A
EPS(TTM)-0.85
EYN/A
EPS(NY)-0.43
Fwd EYN/A
FCF(TTM)-0.39
FCFYN/A
OCF(TTM)-0.33
OCFYN/A
SpS0
BVpS0.58
TBVpS0.57
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -63.17%
ROE -104.21%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-141.78%
ROA(5y)-121.23%
ROE(3y)-219.16%
ROE(5y)-200.3%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 147.79%
Cap/Sales 2522.25%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.2
Quick Ratio 2.2
Altman-Z 3.21
F-Score3
WACC13.01%
ROIC/WACCN/A
Cap/Depr(3y)129.14%
Cap/Depr(5y)158.27%
Cap/Sales(3y)422.93%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-13.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-53.85%
EPS Next Y17%
EPS Next 2Y19.16%
EPS Next 3Y22.09%
EPS Next 5YN/A
Revenue 1Y (TTM)-78.58%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year-89.98%
Revenue Next 2Y214.13%
Revenue Next 3Y327.29%
Revenue Next 5Y290.49%
EBIT growth 1Y-12.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year0.73%
EBIT Next 3Y8.78%
EBIT Next 5YN/A
FCF growth 1Y-42.28%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-36.98%
OCF growth 3YN/A
OCF growth 5YN/A